About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 887 record(s)
Req # A-2022-000016
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-101391-582, Evaluation of the National COVID-19 Exposure Notification App.Organization: Health Canada
February 2023
Req # A-2022-000471
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-105985-788, Deputy Ministerial Meeting with the Health Research Foundation.Organization: Health Canada
February 2023
Req # A-2022-000677
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-107558-330, Deputy Ministerial Meeting with the Patented Medicine Prices Review Board.Organization: Health Canada
February 2023
Req # A-2022-001086
Adverse Drug Reactions (ADRs) for ABILIFY MAINTENA. Report numbers: E2B_05664957, E2B_05664982, E2B_05665009, E2B_05665010, E2B_05651560, E2B_05662861, E2B_05662992, E2B_05662994.Organization: Health Canada
February 2023
Req # A-2022-001090
Adverse Drug Reaction (ADR). Report number: E2B_05211145.Organization: Health Canada
February 2023
Req # A-2022-001130
Adverse Drug Reaction (ADR). Report number: E2B_05731191.Organization: Health Canada
February 2023
Req # A-2022-001229
Adverse Drug Reaction (ADR). Report number: E2B_05826788.Organization: Health Canada
February 2023
Req # A-2022-001369
Adverse Drug Reaction (ADR). Report number: E2B_05880482.Organization: Health Canada
February 2023
Req # A-2018-000066
All records sent, received or transferred by Stakeholder Engagement, Cannabis Legalization and Regulation Branch, Health Canada from March 12, 2018 to April 11, 2018 inclusively.Organization: Health Canada
February 2023
Req # A-2022-000424
All receipts for the expense referred to in Sessional Paper 8555-441-494, tabled in the House of Commons on June 8, 2022, with the following vendor, amount, date of expenditure, and file number: Essential Liquids Inc., $1,799.10, February 18th, 2022…Organization: Health Canada
February 2023